Page 11 - South Korean (KOSPI) Pharmaceuticals & Biotech Stocks - Biggest Losers Today

UPDATED Nov 27, 2024

Explore the South Korean (KOSPI) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

255 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A096530

Seegene
₩23,600.001.9%7.0%₩1.1t₩38,000.00PE37xE35.2%3.4%

A138610

NIBEC
₩16,110.0014.7%-3.5%₩175.5bn/aPS9xn/an/a

A950160

Kolon TissueGene
₩16,690.002.2%86.3%₩1.3tn/an/an/an/a

A003090

Daewoong
₩21,300.003.9%25.4%₩871.0b₩28,000.00PE7.1xS13.8%0.5%

A302440

SK bioscienceLtd
₩48,950.001.1%-27.8%₩3.8t₩49,333.33PS19.1xE70.9%n/a

A128940

Hanmi Pharm
₩283,500.001.4%-4.7%₩3.6t₩399,802.77PE22.4xE12.4%0.2%

A141080

LigaChem Biosciences
₩96,100.001.9%116.4%₩3.5t₩157,428.57PS46xE97.7%n/a

A214450

PharmaResearch
₩207,000.005.5%87.3%₩2.2t₩282,750.00PE23.7xE25.3%0.5%

A145020

Hugel
₩272,000.005.0%79.4%₩3.0t₩360,666.67PE26.8xE20.7%n/a

A326030

SK Biopharmaceuticals
₩99,900.002.3%17.9%₩7.8t₩120,800.00PE136.3xE49.7%n/a

A000100

Yuhan
₩116,300.002.1%97.9%₩8.7t₩128,812.50PE52.6xE21.9%0.4%

A068270

Celltrion
₩177,800.001.3%10.0%₩36.7t₩246,952.38PE195.9xE73.8%0.3%

A196170

ALTEOGEN
₩305,500.002.9%288.7%₩16.3t₩476,666.67PS218.9xE130.7%n/a

A207940

Samsung BiologicsLtd
₩953,000.002.6%30.7%₩67.8t₩1,213,250.00PE64.4xE14.9%n/a

A446600

KAI Biotech
₩6,400.00n/an/a₩6.3bn/an/an/an/a
Page 11 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.